SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Cannabix Technologies Inc. (BLOZF)

A 2010 study published in the journal Psychopharmacology

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
greens12 Member Profile
 
Followed By 201
Posts 17,568
Boards Moderated 3
Alias Born 01/12/12
160x600 placeholder
greens12   Tuesday, 09/26/17 12:55:35 AM
Re: hoyowasobo post# 19191
Post # of 19314 
A 2010 study published in the journal Psychopharmacology concluded that “heavy cannabis users develop tolerance to the impairing effects of THC on neurocognitive task performance.” And a 2012 study in the Journal of Analytical Toxicology confirmed finding “minimal impairment in driving-related psychomotor tasks in chronic daily cannabis users.”
So while the correlation between blood alcohol concentration and impairment is relatively consistent for most people, it may be impossible to establish a THC test that can truly gauge impairment the way a breathalyzer can for booze. Though not for a lack of trying, which creates the danger of severely punishing drivers simply for being cannabis consumers, not for driving while impaired.

"So while the correlation between blood alcohol concentration and impairment is relatively consistent for most people, it may be impossible to establish a THC test that can truly gauge impairment the way a breathalyzer can for booze."

a good lawyer will make BLOZF worthless.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist